SARS-CoV-2 IgG ELISA Kit |
|||
E4901-100 | Biovision | 100 assays | EUR 903.6 |
Human IgG antibody Laboratories manufactures the test for sars-cov-1 antibodies reagents distributed by Genprice. The Test For Sars-Cov-1 Antibodies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Test products are available in stock. Specificity: Test Category: For Group: Sars-Cov-1 Antibodies
SARS-CoV Matrix Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
SARS-CoV Envelope Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Envelope Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Spike Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
Sars-Cov-1 Antibodies information
Cattle Foot and Mouth Disease Virus Type O Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092025-50tests | Abbexa | 50 tests | EUR 427.2 |
Custom Testing of Sample for Human Anti-Mouse Antibodies (HAMA) by ELISA |
|||
200-205-CUX | Alpha Diagnostics | Custom | Ask for price |
SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul |
|||
BSV-COV-AB-02 | BioServUK | 100 ul | Ask for price |
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal) |
Porcine Foot and Mouth Disease Virus Type O Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092022-50tests | Abbexa | 50 tests | EUR 385.2 |
GENLISA™ SARS-CoV-2 (Covid-19) Surrogate Virus Neutralization Test (sVNT) ELISA |
|||
KBVH400 | Krishgen | 12 × 8 wells | EUR 3822 |
anti- SARS antibody |
|||
FNab07609 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against SARS |
Porcine Reproductive and Respiratory Syndrome Virus Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092021-50tests | Abbexa | 50 tests | EUR 385.2 |
Custom Testing of Samples for Antibodies to Human Adenovirus (hAd5 hxn) by ELISA |
|||
950-100-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies to Anthrax Proteins (PA83/LF/EF) by ELISA |
|||
800-100-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Rabies Vaccines by ELISA |
|||
600-020-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Ovalbumin (Gal d2) by ELISA |
|||
670-140-CUX | Alpha Diagnostics | Custom | Ask for price |
Cattle and Goat Foot and Mouth Disease Virus Type O Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092023-50tests | Abbexa | 50 tests | EUR 427.2 |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Cholera Toxins (A/B) by ELISA |
|||
945-100-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Measles/Rubeola vaccines by ELISA |
|||
530-100-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Chikungunya virus (CHIKV) by ELISA |
|||
530-400-CUX | Alpha Diagnostics | Custom | Ask for price |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Diphtheria Toxin/Toxoid by ELISA |
|||
940-090-CUX | Alpha Diagnostics | Custom | Ask for price |
SARS CoV E Protein |
|||
abx060650-1mg | Abbexa | 1 mg | EUR 2030.4 |